Invention Grant
- Patent Title: Nasal compositions stimulating ciliary activity
-
Application No.: US16690821Application Date: 2019-11-21
-
Publication No.: US10751343B2Publication Date: 2020-08-25
- Inventor: Franciscus Wilhelmus Henricus Maria Merkus , Bart Merkus
- Applicant: Innotesto BVBA , Veramed BV
- Applicant Address: BE Kasterlee NL Laren
- Assignee: Innotesto BVBA,Veramed BV
- Current Assignee: Innotesto BVBA,Veramed BV
- Current Assignee Address: BE Kasterlee NL Laren
- Agency: Dinsmore & Shohl, LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@3d6f092f
- Main IPC: A61K31/522
- IPC: A61K31/522 ; A61K9/00 ; A61K47/02 ; A61K9/08

Abstract:
Nasal compositions, comprising an aqueous solution containing caffeine and/or theobromine in a total concentration of up to about 0.5 percent (w/v) and an aqueous carrier having a pH of about 6-8 and comprising physiologically acceptable salts of sodium, potassium and calcium. The nasal composition when used as a nasal spray or as nasal drops or irrigation fluid is able to clean the nasal passages and to stimulate nasal mucociliary clearance and, in contrast to nasal decongestants, may be used on a daily-basis for a period longer than 5 days.
Public/Granted literature
- US20200085831A1 NASAL COMPOSITIONS STIMULATING CILIARY ACTIVITY Public/Granted day:2020-03-19
Information query
IPC分类: